SCHEMBL24792437

SCHEMBL24792437

COCc1nc(O)c2cc(O[C@H]3CCOC3)c(OC)cc2n1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 9/20 0.45
▸ PDE4A P27815 5/20 0.45
▸ PDE4B Q07343 5/20 0.45
▸ PDE4C Q08493 5/20 0.45
▸ SOS1 Q07889 9/20 0.44
▸ ERBB2 P04626 1/20 0.42
▸ EPHA2 P29317 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ EPHB4 P54760 1/20 0.42
▸ KRAS P01116 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ CRBN Q96SW2 1/20 0.42
▸ CHEK1 O14757 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24735665 0.84 SOS1 (0.54) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL24735663 0.84 SOS1 (0.54) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL29125432 0.80 SOS1 (0.47) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL29125430 0.80 SOS1 (0.47) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL28868076 0.74 ERBB2 (0.50) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL30211074 0.74 ERBB2 (0.50) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL28868072 0.74 ERBB2 (0.50) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL23521036 0.73 SOS1 (0.53) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL29988475 0.73 SOS1 (0.57) PDE4DPDE4APDE4BPDE4CSOS1
SCHEMBL24736309 0.72 PDE4D (0.45) PDE4DPDE4APDE4BPDE4CSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022262691-A1 HETEROCYCLIC COMPOUNDS AS SOS1 INHIBITORS BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2022-12-22 — — WO disclosed
Send feedback